过敏性鼻炎的治疗药物研究进展
刘桦,王鹤尧,张佳丽
摘要(Abstract)：
<正>过敏性鼻炎是一种常见病,全球10%～25%的人受到它的困扰。根据粗略估计,我国每年至少有3千万～4千万人患病。过敏性鼻炎分为常年性和季节性。其四大典型症状为:鼻痒、喷嚏、鼻溢液和鼻阻塞。目前国际上治疗过敏性鼻炎的方案主要有远离过敏源、药物疗法、免疫疗法等。现就过敏性鼻炎的药物疗法进行综述。1减充血剂鼻内充血是过敏性鼻炎最严重的症状之一,减充血剂具有拟交感活性,引起鼻黏膜血管收缩而缓
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 刘桦,王鹤尧,张佳丽
DOI: 10.19577/j.cnki.issn10074406.2007.03.024
参考文献(References)：
- [1]Salib RJ,Drake-Lee A,Howarth PH.Allergicrhinitis:past,present and the future[J].Clin Otolaryngol,2003,28(4):291.
- [2]The Allergy Report.American Academy of Allergy,Asthma,& Im- munologyTEB/OJ[EB/OL].http://www.theallergyreport.org/re- portindex.html,2002.04-02
- [3]Bousquet J,van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthma[J].Allergy Clin Immunol,2001,108(5): S147.
- [4]Wood C,Fireman P,Gressman J,et al.Product characteristics and pharmacokinetics of intranasal ipratropium bromide[J].Allergy Clin Im- munol,1995,95(5 Pt 2):1111.
- [5]Gentile DA,Friday GA,Jr,Skoner DP.Management of allergic rhini- tis:antihistamines and decongestants[J].Immunol Allergy Clin,2000,20 (2):355.
- [6]Simpson K,Jarvis B.Fexofenadine:a review of its use in the manage- ment of seasonal allergic rhinitis and chronic idiopathic urticaria[J]. Drugs,2000,59(2):301.
- [7]Day JH,Wllis AK,Rafeiro E.Levocetirizine:a new selective H_1 recepter antagenist fou use in allegro disorders[J].Drugs Today(Barc),2004,40 (5):415.
- [8]Licberman PL,Settipane RA.Azelastine nasal spray:a review of pharma- cology and clinical efficacy inadergic and nonallegic rhinitis[J].Allergy Asthma Proc,2003,24(2):95.
- [9]Howarth PH.Leukotrienes in rhinitis[J].Respir Crit Care Med.2000, 161(2 pt 2):S133.
- [10]Meltzer EO.Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of“one linked airway disease[J].”Ann Allergy Asthma Immunol, 2000,84(2):176.
- [11]Numata T,Kanno A,Yamakoshi T,et al.Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy[J].Ann Otol Rhinol Laryngol,1999,108(5):467.
- [12]van Adelsberg J,Philip G,LaForce CF,et al.Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis[J].Ann Allergy Asthina Immunol,2003,90 (2):214.
- [13]Nayak AS,Philip G,Lu S,et al.Efficacy and tolerability of mon- telukast alone or in combination with loratadine in seasenal allergic rhinitis:a multiconter,randomized,double-blind,placebo-controlled trial performed in the fall[J].Ann Allergy Asthma Immunol,2002,88 (2):592.
- [14]Casale Tb.Prous Science,Omalizamab:an effective anti-IgE trentment for allergic asthma and rhinitis[J].Drugs Today(Barc.),2004,40 (4):367.
- [15]Andrew MW,Paul MO,Krishnan P.Lcokotriene receptor antagonists for allergic rhinitis:a systematic review and meta-analysis[J].Ame J Medi,2004,116(5):338.
- [16]Nathan RA.Pharmacotherapy for allergic rhinitis:a critical review of leukotriene receptor antagonists,compared with other treatments[J]. Ann Allergy Asthma Immunol,2003,90(2):182.
- [17]Nielsen LP,Dahl R.Comparison of inteanasal corticosteroids and anti- histamines in allergic rhinitis:a review of randomized,controlled trials [J].Respir Med,2003,2(1):55.